A retrospective survival analysis of nursing and healthcare associated pneumonia in patients with resistant pathogens

K. Umeki (Yufu, Japan), K. Komiya (Yufu, Japan), Y. Usagawa (Yufu, Japan), Y. Takeno (Yufu, Japan), M. Yamasue (Yufu, Japan), S. Nureki (Yufu, Japan), M. Ando (Yufu, Japan), K. Hiramatsu (Yufu, Japan), J. Kadota (Yufu, Japan)

Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Session: Improving the outcomes of community-acquired pneumonia
Session type: Poster Discussion
Number: 2025
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Umeki (Yufu, Japan), K. Komiya (Yufu, Japan), Y. Usagawa (Yufu, Japan), Y. Takeno (Yufu, Japan), M. Yamasue (Yufu, Japan), S. Nureki (Yufu, Japan), M. Ando (Yufu, Japan), K. Hiramatsu (Yufu, Japan), J. Kadota (Yufu, Japan). A retrospective survival analysis of nursing and healthcare associated pneumonia in patients with resistant pathogens. 2025

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


An RDW-based clinical model predicts long-term survival in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation multicentric study
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Are severity scores for community acquired pneumonia being used in secondary care and its impact on appropriateness of antibiotic therapy - a retrospective study
Source: Eur Respir J 2004; 24: Suppl. 48, 187s
Year: 2004

Clinical outcomes of the patients with multidrug-resistant Acinetobacter baumannii pneumonia in critical care setting: A retrospective cohort study in Taiwan
Source: International Congress 2018 – Preclinical and clinical studies of critical illness
Year: 2018


A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia
Source: Eur Respir J 2001; 18: 362-368
Year: 2001



The impact of a stewardship programme on outcomes in patients admitted with community-acquired pneumonia
Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Year: 2020




Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007


Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation
Source: Eur Respir J 2004; 24: Suppl. 48, 414s
Year: 2004

Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005


Female gender is associated with poor clinical outcomes in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Improving outcome in elderly patients with pneumonia
Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI
Year: 2005

The general evaluation of elderly patients with community acquired pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 412s
Year: 2004

Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009


The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007


A worldwide perspective of the level of compliance with guidelines in hospitalized patients with community-acquired pneumonia: results from the CAPO cohort international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


The effects of antibiotic therapy at the pre-hospital stage on the in-hospital mortality in adults with community-acquired pneumonia in Russia: observational study results.
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Guideline-concordant therapy and outcomes in healthcare-associated pneumonia
Source: Eur Respir J 2011; 38: 878-887
Year: 2011



Health care associated pneumonia versus community acquired pneumonia: Comparison of etiology, treatment and prognosis
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012


The extent of microbiological testing and antibiotic de-escalation in adults with community-acquired pneumonia: a retrospective cohort study.
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018